Pharmaceutical Technology lists ten of the most popular tweets on oncology in February 2020, based on data from GlobalData’s Influencer Platform. The top tweets were chosen from influencers as tracked by GlobalData’s Influencer Platform, which is based on a scientific process that works on pre-defined parameters. Influencers are selected after a deep analysis of the influencer’s relevance, network strength, engagement, and leading discussions on new and emerging trends.

Top tweets on oncology in February 2020

1. Eric Topol’s tweet on the promises and challenges of genome editing

Eric Topol, founder and director of the Scripps Research Translational Institute, shared an article on the therapeutic opportunities and challenges of genome editing. The article further noted the use of CRISPR (clustered regularly interspaced short palindromic repeats) oncology technology for treatment in humans. Genome editing can be applied to several diseases such as Duchenne muscular dystrophy and sickle disease anaemia. It is being tested for further therapeutic applications.

Username: Eric Topol

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Twitter handle: @EricTopol

Retweets: 230

Likes: 497

2. Atul Gawande’s tweet on the lapses in oncology medical care for sick inmates

Atul Gawande, founder and chairman of Ariadne Labs, shared an article on how Alabama sheriffs are releasing sick or injured jail inmates to evade medical bills. The article further noted that these inmates were rearrested when they recovered, and that many have died due to substandard treatment being given to sick oncology inmates.

The article gives an account of many inmates being released due to medical emergencies under the ‘medical bond’ clause, which the sheriffs were following in local jails across the country.

Username: Atul Gawande

Twitter handle: @Atul_Gawande

Retweets: 71

Likes: 160

3. Jennifer Gunter’s oncology tweet on Reiki being ineffective

Jennifer Gunter, an obstetrician-gynaecologist, tweeted on Reiki trials being ineffective in improving outcomes. The influencer stated that people did better with chemotherapy when they had companionship.

Username: Jennifer Gunter

Twitter handle: @DrJenGunter

Retweets: 54

Likes: 1,295

4. Liz O’Riordan’s tweet on a photographic exhibition plan to help breast cancer patients cope better

Liz O’Riordan, a consultant breast cancer surgeon, shared an article on how photography can be used to help patients relate with breast cancer. The influencer noted that her own photographs after having undergone a mastectomy seemed empowering and therapeutic.

The article further noted that the influencer is looking to create a photographic exhibition along with photographer Alex Kilbeeto, to shed light on the emotions of breast cancer survivors.

Username: Liz O’Riordan

Twitter handle: @Liz_ORiordan

Retweets: 41

Likes: 150

5. Anirban Maitra’s tweet on increased intratumoural heterogeneity in small-cell lung cancer

Anirban Maitra, the scientific director of the Ahmed Center for Pancreatic Cancer Research, shared an article on the increased occurrence of tumours following the beginning of therapy resistance in situations such as small-cell lung cancer (SCLC). The article further noted that clinical efforts should be focused on rational combination therapies to counter the occurrence of ITH and other resistance mechanisms.

Username: Anirban Maitra

Twitter handle: @Aiims1742

Retweets: 40

Likes: 110

6. FabriceAndre’s tweet on chemotherapy and pembrolizumab for high-risk, early-stage breast cancer

FabriceAndre, an oncologist at Gustave Roussy, shared an article on a study to assess the safety and preliminary antitumor activity of neoadjuvant chemotherapy and pembrolizumab in high-risk, early-stage, non-metastatic triple-negative breast cancer (TNBC). The study confirmed manageable toxicity and promising antitumor activity.

Username: FabriceAndre

Twitter handle: @FAndreMD

Retweets: 39

Likes: 88

7. G Garcia-Manero’s tweet on blood advances

G Garcia-Manero, a Leukaemia physician and professor of medicine, shared an article on the analysis of the impact of p53 mutation in Myelodysplastic syndromes (MDS). The study evaluated the type, number, and patterns of TP53 mutations in response outcomes and development of MDS.

Username: G Garcia-Manero

Twitter handle: @garciamanero

Retweets: 26

Likes: 91

8. David Gandara’s tweet on the first potential treatment for non-small cell lung cancer

David Gandara, a medical oncologist and clinical-translational researcher in lung cancer, shared an article on the FDA’s acceptance and priority review of capmatinib (INC280) for treating patients with locally advanced or metastatic MET exon 14 skipping (METex14) mutated non-small cell lung cancer (NSCLC).

Capmatinib (INC280) is an investigational, oral, and selective MET inhibitor licensed to Novartis by Incyte Corporation in 2009.

Username: David Gandara

Twitter handle: @drgandara

Retweets: 24

Likes: 58

9. Julie Gralow’s oncology tweet on how to manage male breast cancer

Julie Gralow, the director of breast medical oncology at Seattle Cancer Care Alliance, shared an article on ways to manage male breast cancer. The guideline developed recommendations based on formal consensus and review. It stated that most of the approaches were similar to that for women. Drug administration, annual mammograms, genetic counselling, and germline genetic testing were some of the listed approaches.

Username: Julie Gralow

Twitter handle: @jrgralow

Retweets: 22

Likes: 56

10. Vincent Rajkumar’s tweet on the utility of serum free light chain ratio in response assessment in myeloma

Vincent Rajkumar, a professor of medicine at the Mayo Clinic, shared an article on the utility of serum free light chain (FLC) ratio in response definition in patients with multiple myeloma. The study suggested that the sFLC ratio should be interpreted with caution, especially in the setting of complete response.

Username: Vincent Rajkumar

Twitter handle: @VincentRK

Retweets: 16

Likes: 56